C12Y 301/01028
Acylcarnitine hydrolase
Official title: Acylcarnitine hydrolase (3.1.1.28)
C12Y301/01028 (Acylcarnitine hydrolase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 2
- Inventors
- 6
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified mammalian cells9 Apr 2026US 2026/0098254 A1Genentech, Inc.
- Enhancing formation of human milk oligosaccharides (hmos) by modifying lactose import in the cell15 Jan 2026US 2026/0015636 A1Dsm IP Assets B.V.
- Modified mammalian cells27 Mar 2025US 2025/0101411 A1Genentech, Inc.
- Enhancing formation of human milk oligosaccharides (hmos) by modifying lactose import in the cell22 Aug 2024US 2024/0279697 A1Dsm IP Assets B.V.
- Modified mammalian cells7 Oct 2021US 2021/0309989 A1Genentech, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.